文献速递前列腺癌

LaserSAFE技术用于根治性前列腺切除术切缘评估的可行性研究

The LaserSAFE technique for margin assessment during radical prostatectomy: a feasibility study.
PubMed 文献 · BJU Int · 2025-11-27

这项非随机前瞻性可行性研究在单一高容量学术中心纳入20例拟行机器人辅助根治性前列腺切除术的局限期前列腺癌患者,评估基于共聚焦激光显微镜的LaserSAFE技术实时评估手术切缘的可行性及诊断性能。LaserSAFE检测≥0.5 mm阳性切缘的敏感度为0.91(95%CI 0.59-1.00),特异度为1.00(95%CI 0.88-1.00),与NeuroSAFE及最终病理高度一致,中位完成时间7分钟,显著短于NeuroSAFE的63分钟;但多中心扩展因NeuroSAFE方案实施限制未能实现。

要点

  • LaserSAFE检测≥0.5 mm阳性切缘敏感度0.91、特异度1.00,与NeuroSAFE及最终病理高度一致。
  • LaserSAFE中位完成时间7分钟,显著短于NeuroSAFE的63分钟。
  • 多中心扩展因NeuroSAFE方案实施限制未实现,支持设计以LaserSAFE指导神经保留决策的更大试验。

核心结论

  • 以NeuroSAFE为对照的多中心研究未能实现,但LaserSAFE被证明是术中切缘评估的快速、准确替代方法。
  • 研究结果支持设计更大规模试验,由LaserSAFE指导神经保留决策,以扩大实时切缘评估的可及性。

研究设计与样本

  • 非随机前瞻性可行性研究,在英国一家高容量学术中心开展(ClinicalTrials.gov标识NCT06398470)。
  • 纳入局限期前列腺癌(临床T2-T3a N0 M0)拟行机器人辅助根治性前列腺切除术、经多学科计划判定不适合双侧筋膜内神经保留的患者。
  • LaserSAFE成像在手术室完成,随后NeuroSAFE技术结果指导神经保留决策;病理医师对NeuroSAFE和最终组织学设盲,回顾性评估LaserSAFE图像。
  • 计算诊断准确性指标及两种方法间的一致性;可行性依据招募率和激活额外中心的能力评估。

主要发现

  • 12个月内在单一中心招募20例患者。
  • 因NeuroSAFE方案实施限制,扩展至额外中心不可行。
  • LaserSAFE检测≥0.5 mm阳性手术切缘的敏感度为0.91(95%CI 0.59-1.00),特异度为1.00(95%CI 0.88-1.00)。
  • Cohen's kappa显示LaserSAFE与NeuroSAFE及最终病理高度一致。
  • LaserSAFE中位完成时间7分钟,显著短于NeuroSAFE所需的63分钟。

关键数值与推荐

  • LaserSAFE检测≥0.5 mm阳性手术切缘:敏感度0.91(95%CI 0.59-1.00),特异度1.00(95%CI 0.88-1.00)。
  • LaserSAFE中位完成时间7分钟,NeuroSAFE为63分钟。
  • Cohen's kappa显示LaserSAFE与NeuroSAFE及最终病理高度一致。

临床怎么用

  • LaserSAFE可在术中快速完成切缘评估,中位7分钟,显著短于NeuroSAFE的63分钟。
  • LaserSAFE检测≥0.5 mm阳性切缘的敏感度0.91、特异度1.00,与NeuroSAFE及最终病理高度一致。
  • 当前研究未基于LaserSAFE结果进行术中决策,其指导神经保留决策的临床应用尚待更大试验验证。

局限性

  • 样本量小(20例)。
  • 单中心设置。
  • 缺乏基于LaserSAFE发现进行术中决策。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To assess the feasibility of conducting a multicentre trial comparing NeuroSAFE with a novel technique based on confocal laser microscopy (LaserSAFE) and evaluate the diagnostic performance of LaserSAFE for real-time surgical margin assessment. PATIENTS AND METHODS: This was a non-randomised, prospective feasibility study conducted at a high-volume academic UK centre (ClinicalTrials.gov identifier: NCT06398470). Patients with localised prostate cancer (clinical T2-T3a N0 M0) scheduled for robot-assisted radical prostatectomy and deemed unsuitable for bilateral intrafascial nerve sparing (NS) based on a multidisciplinary plan were included. LaserSAFE imaging was performed in the operating room after which the NeuroSAFE technique results guided NS decisions. Pathologists, blinded to NeuroSAFE and final histology, retrospectively evaluated LaserSAFE images. Diagnostic accuracy metrics and concordance between modalities were calculated. Feasibility was assessed based on recruitment rate and the ability to activate additional sites. RESULTS: A total of 20 patients were recruited at a single site within 12 months of recruitment start. However, expansion to additional centres was not feasible due to limitations in implementing the NeuroSAFE protocol. LaserSAFE achieved a sensitivity of 0.91 (95% confidence interval [CI] 0.59-1.00) and specificity of 1.00 (95% CI 0.88-1.00) for detecting positive surgical margins ≥0.5 mm. Cohen's kappa demonstrated strong agreement with NeuroSAFE and final pathology. LaserSAFE was completed within a median of 7 min, significantly shorter than the 63 min required for NeuroSAFE. Limitations include the small sample size, single-centre setting, and lack of intraoperative decision-making based on LaserSAFE findings. CONCLUSION: While a multicentre study based on NeuroSAFE as a comparison was not achievable, LaserSAFE proved to be a rapid and accurate alternative for intraoperative margin assessment. These findings support the design of a larger trial in which NS decisions are informed by LaserSAFE, with a view to broadening access to real-time margin assessment.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Almeida-Magana R, Mendes LST, Dinneen E, et al. The LaserSAFE technique for margin assessment during radical prostatectomy: a feasibility study. BJU Int. 2025. PMID: 41309506. doi:10.1111/bju.70092

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。